Cargando…

Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches

Spondias mangifera is a drupaceous fruit popular for its flavour and health advantages. There is little scientific knowledge about S. mangifera, despite its widespread usage in traditional medicine, in the North-Eastern region of India. Inhibiting the key carbohydrate hydrolysing enzymes is one of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalid, Mohammad, Alqarni, Mohammed H., Alsayari, Abdulrhman, Foudah, Ahmed I., Aljarba, Tariq M., Mukim, Mohammad, Alamri, Mubarak A., Abullais, Shahabe Saquib, Wahab, Shadma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880729/
https://www.ncbi.nlm.nih.gov/pubmed/35214895
http://dx.doi.org/10.3390/plants11040562
_version_ 1784659291720908800
author Khalid, Mohammad
Alqarni, Mohammed H.
Alsayari, Abdulrhman
Foudah, Ahmed I.
Aljarba, Tariq M.
Mukim, Mohammad
Alamri, Mubarak A.
Abullais, Shahabe Saquib
Wahab, Shadma
author_facet Khalid, Mohammad
Alqarni, Mohammed H.
Alsayari, Abdulrhman
Foudah, Ahmed I.
Aljarba, Tariq M.
Mukim, Mohammad
Alamri, Mubarak A.
Abullais, Shahabe Saquib
Wahab, Shadma
author_sort Khalid, Mohammad
collection PubMed
description Spondias mangifera is a drupaceous fruit popular for its flavour and health advantages. There is little scientific knowledge about S. mangifera, despite its widespread usage in traditional medicine, in the North-Eastern region of India. Inhibiting the key carbohydrate hydrolysing enzymes is one of the strategies for managing diabetes. Therefore, this study studied the antioxidant and anti-diabetic properties of different fraction S. mangifera fruit extract (SMFFs) from Indian geographical origin by in vitro experimental assays and silico docking simulation studies. The ADMET prediction for active substances was also investigated using the AdmetSAR database. Based on the binding affinity/molecular interactions between phytocompounds and target enzymes, in silico investigations were done to confirm the in vitro enzymatic inhibitory capability. β-sitosterol in EtOH-F was analysed using RP-HPLC with RP-C18 column as stationary phase and photo diode array detector. The percentage of β-sitosterol was found to be 1.21% ± 0.17% of total weight of extract (w/w). S. mangifera fruit ethanolic extract had a significant inhibitory concentration of 50% against free radicals produced by ABTS (89.71 ± 2.73%) and lipid peroxidation assay (88.26 ± 2.17%) tests. Similarly, the in vitro antidiabetic test findings indicated that S. mangifera inhibited alpha-amylase (73.42 ± 2.01%) and alpha-glucosidase (79.23 ± 1.98%) enzymes dose-dependently. The maximum glycosylated Hb percentage inhibitory activity shown in the ethanolic fraction was (83.97 ± 2.88%) at 500 µg/mL. The glucose uptake of the ethanolic fraction by the yeast cell showed significant (p < 0.05) at 500 µg/mL when compared with metformin (91.37 ± 1.59%), whereas the other fraction did not show the uptake of glucose by the yeast cell at the same concentration. In the docking study, the main phytoconstituents of S. mangifera fruit, such as oleanolic acid, beta-sitosterol, and beta amyrin, show strong affinity for pancreatic α-amylase. These results imply that S. mangifera has α-amylase and α-glucosidase inhibitory properties and may be used as antidiabetic with antioxidant characteristics.
format Online
Article
Text
id pubmed-8880729
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88807292022-02-26 Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches Khalid, Mohammad Alqarni, Mohammed H. Alsayari, Abdulrhman Foudah, Ahmed I. Aljarba, Tariq M. Mukim, Mohammad Alamri, Mubarak A. Abullais, Shahabe Saquib Wahab, Shadma Plants (Basel) Article Spondias mangifera is a drupaceous fruit popular for its flavour and health advantages. There is little scientific knowledge about S. mangifera, despite its widespread usage in traditional medicine, in the North-Eastern region of India. Inhibiting the key carbohydrate hydrolysing enzymes is one of the strategies for managing diabetes. Therefore, this study studied the antioxidant and anti-diabetic properties of different fraction S. mangifera fruit extract (SMFFs) from Indian geographical origin by in vitro experimental assays and silico docking simulation studies. The ADMET prediction for active substances was also investigated using the AdmetSAR database. Based on the binding affinity/molecular interactions between phytocompounds and target enzymes, in silico investigations were done to confirm the in vitro enzymatic inhibitory capability. β-sitosterol in EtOH-F was analysed using RP-HPLC with RP-C18 column as stationary phase and photo diode array detector. The percentage of β-sitosterol was found to be 1.21% ± 0.17% of total weight of extract (w/w). S. mangifera fruit ethanolic extract had a significant inhibitory concentration of 50% against free radicals produced by ABTS (89.71 ± 2.73%) and lipid peroxidation assay (88.26 ± 2.17%) tests. Similarly, the in vitro antidiabetic test findings indicated that S. mangifera inhibited alpha-amylase (73.42 ± 2.01%) and alpha-glucosidase (79.23 ± 1.98%) enzymes dose-dependently. The maximum glycosylated Hb percentage inhibitory activity shown in the ethanolic fraction was (83.97 ± 2.88%) at 500 µg/mL. The glucose uptake of the ethanolic fraction by the yeast cell showed significant (p < 0.05) at 500 µg/mL when compared with metformin (91.37 ± 1.59%), whereas the other fraction did not show the uptake of glucose by the yeast cell at the same concentration. In the docking study, the main phytoconstituents of S. mangifera fruit, such as oleanolic acid, beta-sitosterol, and beta amyrin, show strong affinity for pancreatic α-amylase. These results imply that S. mangifera has α-amylase and α-glucosidase inhibitory properties and may be used as antidiabetic with antioxidant characteristics. MDPI 2022-02-21 /pmc/articles/PMC8880729/ /pubmed/35214895 http://dx.doi.org/10.3390/plants11040562 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khalid, Mohammad
Alqarni, Mohammed H.
Alsayari, Abdulrhman
Foudah, Ahmed I.
Aljarba, Tariq M.
Mukim, Mohammad
Alamri, Mubarak A.
Abullais, Shahabe Saquib
Wahab, Shadma
Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches
title Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches
title_full Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches
title_fullStr Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches
title_full_unstemmed Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches
title_short Anti-Diabetic Activity of Bioactive Compound Extracted from Spondias mangifera Fruit: In-Vitro and Molecular Docking Approaches
title_sort anti-diabetic activity of bioactive compound extracted from spondias mangifera fruit: in-vitro and molecular docking approaches
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880729/
https://www.ncbi.nlm.nih.gov/pubmed/35214895
http://dx.doi.org/10.3390/plants11040562
work_keys_str_mv AT khalidmohammad antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT alqarnimohammedh antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT alsayariabdulrhman antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT foudahahmedi antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT aljarbatariqm antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT mukimmohammad antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT alamrimubaraka antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT abullaisshahabesaquib antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches
AT wahabshadma antidiabeticactivityofbioactivecompoundextractedfromspondiasmangiferafruitinvitroandmoleculardockingapproaches